Loading...
Derniers dépôts
-
Marissa Gionet-Gonzales, Alena Casella, Daphne Diloretto, Clara Ginnell, Katherine Griffin, et al.. Sulfated Alginate Hydrogels Prolong the Therapeutic Potential of MSC Spheroids by Sequestering the Secretome. Advanced Healthcare Materials, 2021, 10 (21), pp.2101048. ⟨10.1002/adhm.202101048⟩. ⟨hal-03832652⟩
-
Maria Chatzifrangkeskou, Caroline Le Dour, Wei Wu, John Morrow, Leroy Joseph, et al.. ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene. Human Molecular Genetics, 2016, 25 (11), pp.2220-2233. ⟨10.1093/hmg/ddw090⟩. ⟨hal-03862965⟩
-
Emmanuelle Salort-Campana, Guilhem Solé, Armelle Magot, Céline Tard, Jean-Baptiste Noury, et al.. Multidisciplinary team meetings in treatment of spinal muscular atrophy adult patients: a real-life observatory for innovative treatments. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.24. ⟨10.1186/s13023-023-03008-6⟩. ⟨hal-04667757⟩
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Francesco Galli, Laricia Bragg, Maira Rossi, Daisy Proietti, Laura Perani, et al.. Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy. EMBO Molecular Medicine, 2024, 16 (4), pp.927 - 944. ⟨10.1038/s44321-024-00031-3⟩. ⟨hal-04603972⟩
-
Julia Pereira Lemos, Liliane Patrícia Gonçalves Tenório, Vincent Mouly, Gillian Butler-Browne, Daniella Arêas Mendes-Da-Cruz, et al.. T cell biology in neuromuscular disorders: a focus on Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis. Frontiers in Immunology, 2023, 14, pp.120283. ⟨10.3389/fimmu.2023.1202834⟩. ⟨hal-04603915⟩
Nombre de documents
796
Nombre de notices
1 383
widget_cloud
Autoimmunity
Dynamin 2
Male
Fibrosis
MBNL
Aging
Myotonic dystrophy type 1
Muscular dystrophy
AAV
Outcome measures
Myotonic dystrophy
PABPN1
FSHD
Duchenne muscular dystrophy
LMNA
Cytoskeleton
Heart failure
Alternative splicing
Fabry disease
COVID-19
RNA interference
Muscle
Congenital muscular dystrophy
Heart
Treatment
Laminopathie
Myasthenia Gravis MG
Myopathies
Myotonic Dystrophy
Autoimmune diseases
Thérapie génique
CTG repeat contractions
Cell therapy
Humans
DMD
Autoantibodies
Satellite cells
Exercise
Myasthenia gravis
Antisense oligonucleotides
RNA biology
Animals
Genotype phenotype correlation
Mechanotransduction
Transcriptomics
Calcium
Regeneration
Congenital myopathy
Laminopathy
Spinal muscular atrophy
Cytokines
ALS
Neuromuscular disease
Myogenesis
Laminopathies
Astrocyte
Mouse model
Actin
Nuclear envelope
Gene therapy
Biomarker
Errance diagnostique
Neuromuscular diseases
CMS
Biomarkers
Skeletal muscle
Becker muscular dystrophy
OPMD
Transgenic mouse model
Autophagy
Lamin A/C
Rare diseases
Motoneuron
Lamin A/C LMNA gene
Brain
Cardiomyopathy
CRISPRi
Therapy
Myopathy
Neuromuscular junction
Inflammation
Thymus
Mice
Myotonic Dystrophy type 1
Rare neuromuscular diseases
Amyotrophic lateral sclerosis
Cancer
Trinucleotide repeat expansion
Dilated cardiomyopathy
Aged
Glutamate
Centronuclear myopathy
Satellite cell
LMNA gene
Dermatomyositis
Myoblasts
Dystrophin
Long read sequencing
Muscle regeneration
Myositis